)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
CNS Pharmaceuticals
CNS Pharmaceuticals (CNSP) investor relations material
CNS Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary25 Aug, 2026
Executive summary
Annual meeting scheduled for September 30, 2026, at 12:00 PM EST, to be held virtually.
Shareholders are encouraged to review materials and vote on key proposals affecting governance and compensation.
Voting matters and shareholder proposals
Election of six directors for terms expiring at the 2027 annual meeting or until successors are elected.
Ratification of MaloncBailey, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory, non-binding vote on executive compensation.
Approval of amendments to the 2020 Stock Plan, including an increase of 650,000 authorized shares.
Authorization to adjourn the meeting if additional proxy solicitation is needed.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and amendments to the stock plan.
Director nominees include Faith Charles, Bettina Cockroft, Michal Fisher, Jeffry R. Keyes, Rami Levin, and Amy Mahery.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CNS Pharmaceuticals
- Shareholders will vote on director elections, auditor ratification, say-on-pay, and stock plan amendments.CNSP
Proxy filing - Strategic pivot targets high-value oncology and neurology assets with strong financial backing.CNSPInvestor presentation
- Net loss widened on higher expenses, but strong cash and new financing support strategic growth.CNSPQ2 2026
- Nearly 9.8 million shares registered for resale may cause significant dilution and price pressure.CNSPRegistration filing
- Strategic shift, $4.94M Q1 loss, and $22.5M May financing extend runway for acquisitions.CNSPQ1 2026
- Strategic pivot targets neurology and oncology with a new leadership team and asset-focused growth.CNSPInvestor presentation
- Strategic shift to neurology and oncology drives higher R&D costs and ongoing going concern risk.CNSPQ4 2025
- Pivotal brain cancer trial nears data, with new pipeline asset and strong financial footing.CNSPVirtual Investor CEO Connect
- TPI 287 was in-licensed, showing strong GBM efficacy and will enter pivotal trials in 2025.CNSPInvestor Update
Next CNS Pharmaceuticals earnings date
Q3 202613 Nov, 2026
CNS Pharmaceuticals
Next CNS Pharmaceuticals earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage